Vontobel Swiss Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-38,054
Closed -$3.43M 120
2019
Q1
$3.43M Buy
38,054
+3,146
+9% +$282K 3.72% 10
2018
Q4
$3.13M Buy
34,908
+12,955
+59% +$1.21M 2.33% 14
2018
Q3
$2.16M Sell
21,953
-1,605
-7% -$148K 1.27% 25
2018
Q2
$2.02M Sell
23,558
-820
-3% -$68.5K 1.14% 26
2018
Q1
$1.96M Buy
24,378
+155
+0.6% +$12.8K 1.03% 29
2017
Q4
$1.96M Sell
24,223
-420
-2% -$33.6K 1.15% 30
2017
Q3
$1.92M Buy
24,643
+2,150
+10% +$179K 1.17% 30
2017
Q2
$2M Sell
22,493
-1,247
-5% -$105K 1.27% 22
2017
Q1
$1.91M Buy
23,740
+403
+2% +$31.5K 1.04% 28
2016
Q4
$1.66M Buy
23,337
+18,987
+436% +$1.49M 1.02% 35
2016
Q3
$376K Buy
+4,350
New +$379K 0.2% 50

Other funds holding MDT

Vontobel Swiss Wealth Advisors's MDT Position: Q2 2019 in Review

Vontobel Swiss Wealth Advisors sold out of Medtronic (MDT) in Q2 2019, closing a stake of 38,054 shares — an estimated $3.43M sold.

Vontobel Swiss Wealth Advisors first reported a position in MDT in Q3 2016 and held it in 11 quarters. The position peaked at $3.43M in Q1 2019. 1,619 funds tracked by Wall St. Rank hold MDT as of Q2 2019.

  • Vontobel Swiss Wealth Advisors reported no remaining Medtronic position as of Q2 2019 after selling out during the quarter.
  • Vontobel Swiss Wealth Advisors sold 38,054 Medtronic shares in Q2 2019, an estimated $3.43M.
  • Vontobel Swiss Wealth Advisors first reported a position in Medtronic in Q3 2016 and held it in 11 quarters.
  • Vontobel Swiss Wealth Advisors's Medtronic position peaked at $3.43M in Q1 2019.
  • 1,619 funds tracked by Wall St. Rank held Medtronic as of Q2 2019.

Based on Vontobel Swiss Wealth Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.